ArticleJournal of medicinal chemistry2021

Design and Evaluation of Peptide Dual-Agonists of GLP-1 and NPY2 Receptors for Glucoregulation and Weight Loss with Mitigated Nausea and Emesis.

Brandon T Milliken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.